China To Issue New National Reimbursement List In November
This article was originally published in The Pink Sheet Daily
Executive Summary
Multinational companies will likely see lower prices due to a new price negotiation system.
You may also be interested in...
Chinese Premier Wen Jiabao Allocates Healthcare Investment, But Essential Drug List Delayed Again
SHANGHAI - China's State Council issued additional healthcare reform plans July 8 to detail the goals of the country's ambitious reform plan. However, the release of the long-awaited essential drug list will be delayed to the end of this year, which was expected to be issued by June
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
SHANGHAI - China's essential drug system will hasten the consolidation of the generic industry while a measure for drug pricing will encourage innovation, according to a Frost & Sullivan report on the impact of China's healthcare reform, released May 18
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.